Zobrazeno 1 - 10
of 1 532
pro vyhledávání: '"isavuconazole"'
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background Sunitinib, a newly developed multi-targeted tyrosine kinase inhibitor (TKI), has become a common therapeutic option for managing advanced renal cell carcinoma (RCC). Examining the mechanism underlying the interaction between sunit
Externí odkaz:
https://doaj.org/article/88eb762f5aae4fe0a0f8b15f1fd87a9c
Publikováno v:
Infection and Drug Resistance, Vol Volume 17, Pp 2159-2168 (2024)
Xue Ting Tan, Nurin Nazirah Binti Mokhtar, Shirley Yi Fen Hii, Fairuz Amran Bacteriology Unit, Infectious Diseases Research Centre, Institute for Medical Research, National Institute of Health, Ministry of Health Malaysia, Setia Alam, Selangor, Malay
Externí odkaz:
https://doaj.org/article/de5b4ef86e754cb999098b82136495c1
Autor:
Patricia Monzó-Gallo, Carlos Lopera, Ana M Badía-Tejero, Marina Machado, Julio García-Rodríguez, Pablo Vidal-Cortés, Esperanza Merino, Jorge Calderón, Jesús Fortún, Zaira R. Palacios-Baena, Javier Pemán, Joan Roig Sanchis, Manuela Aguilar-Guisado, Carlota Gudiol, Juan C Ramos, Isabel Sánchez-Romero, Pilar Martin-Davila, Luis E. López-Cortés, Miguel Salavert, Isabel Ruiz-Camps, Mariana Chumbita, Tommaso Francesco Aiello, Olivier Peyrony, Pedro Puerta-Alcalde, Alex Soriano, Francesc Marco, Carolina Garcia-Vidal
Publikováno v:
International Journal of Infectious Diseases, Vol 144, Iss , Pp 107070- (2024)
ABSTRACT: Objectives: Information is scarce on clinical experiences with non-neutropenic patients with invasive fungal infection (IFI) receiving isavuconazole. We aimed to report the safety and effectiveness of this drug as a first-line treatment or
Externí odkaz:
https://doaj.org/article/f27134717cc642c0ac24d31db5e168ce
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
Disseminated candidiasis is a severe complication in patients with hematological malignancies who have undergone chemotherapy or hematopoietic stem cell transplantation. It has a high mortality rate. When disseminated candidiasis caused by Candida tr
Externí odkaz:
https://doaj.org/article/97b17748b8ac4bf59123f210c607434d
Publikováno v:
Contemporary Clinical Trials Communications, Vol 39, Iss , Pp 101310- (2024)
Background: During the early stages of the coronavirus disease 2019 (COVID-19) pandemic, those with severe COVID-19 infection were at risk for a number of opportunistic infections including COVID-19-associated pulmonary aspergillosis (CAPA). We initi
Externí odkaz:
https://doaj.org/article/aa9bd553190a4ee08d871018ebb11caf
Autor:
Veselov A.V.
Publikováno v:
Клиническая микробиология и антимикробная химиотерапия, Vol 25, Iss 4, Pp 379-394 (2023)
The steadily increasing incidence of invasive fungal infections, influenced to some extent by the COVID-19 pandemic, caused by both yeast and molds makes it necessary to improve the antifungal therapies used. Historically, azoles have held a key posi
Externí odkaz:
https://doaj.org/article/fc0a5979a64e4c6e9811e020eb7a22b9
Publikováno v:
Infection and Drug Resistance, Vol Volume 16, Pp 7559-7568 (2023)
Na Chen,1,2 Xiaojuan Wang,1,2 Yinyan Li,1,2 Ping Yang,1,2 Mingzhu Huang,1,2 Xiaoyang Lu1,2 1Department of Pharmaceutical, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, People’s Republic of China
Externí odkaz:
https://doaj.org/article/9b1384be6e8a424b945783462cc8cbc8
Autor:
Vanessa Gow-Lee, Omar M. Abu Saleh, Courtney E. Harris, Jennifer J. Gile, Nadia Akhiyat, Supavit Chesdachai
Publikováno v:
Pathogens, Vol 13, Iss 10, p 886 (2024)
Background: Isavuconazole (ISA) has a favorable side effect profile that makes it attractive for treatment of invasive fungal infections (IFI). It carries FDA approval for invasive aspergillosis and mucormycosis, but there are fewer data for other or
Externí odkaz:
https://doaj.org/article/cd380215743d46f7be687fae66b01b64
Autor:
Frontiers Production Office
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Externí odkaz:
https://doaj.org/article/1b0426998d3f4a0db631a1ad0dee0658
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
IntroductionTriazole antifungal agents are widely used to treat and prevent systemic mycoses. With wide clinical use, the number of reported adverse events has gradually increased. The aim of this study was to analyze the cardiac disorders associated
Externí odkaz:
https://doaj.org/article/5dc4a758e4c7440bb8eb717fa27474c8